(Q34521765)

2 August 2017

1 reference

title

Risk factors for bronchiolitis obliterans: a systematic review of recent publications (English)

1 reference

2 August 2017

0 references

1 reference

bronchiolitis obliterans

1 reference

Linda D Sharples

1

1 reference

2 August 2017

Keith McNeil

series ordinal

2

1 reference

2 August 2017

Susan Stewart

series ordinal

3

1 reference

2 August 2017

John Wallwork

series ordinal

4

1 reference

2 August 2017

1 February 2002

1 reference

The Journal of Heart and Lung Transplantation

2 August 2017

1 reference

2 August 2017

21

1 reference

2 August 2017

271-281

1 reference

2 August 2017

2

1 reference

Post-transplant obliterative bronchiolitis and other late lung sequelae in human heart-lung transplantation

2 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900360-6

7 January 2021

Transforming growth factor beta (TGF-beta) and obliterative bronchiolitis following pulmonary transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900360-6

7 January 2021

Bronchiolitis obliterans in recipients of single, double, and heart-lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900360-6

7 January 2021

HLA-A locus mismatches and development of antibodies to HLA after lung transplantation correlate with the development of bronchiolitis obliterans syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900360-6

7 January 2021

Obliterative bronchiolitis after lung and heart-lung transplantation. An analysis of risk factors and management

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900360-6

7 January 2021

Analysis of risk factors for the development of bronchiolitis obliterans syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900360-6

7 January 2021

ATG induction therapy and the incidence of bronchiolitis obliterans after lung transplantation: does it make a difference?

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900360-6

7 January 2021

Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900360-6

7 January 2021

Does bronchial artery revascularization influence results concerning bronchiolitis obliterans syndrome and/or obliterative bronchiolitis after lung transplantation?

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900360-6

7 January 2021

Surveillance transbronchial lung biopsies: implication for survival after lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900360-6

7 January 2021

Does human leukocyte antigen matching influence the outcome of lung transplantation? An analysis of 3,549 lung transplantations

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900360-6

7 January 2021

The influence of HLA compatibility on graft survival after heart transplantation. The Collaborative Transplant Study

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900360-6

7 January 2021

Effect of development of antibodies to HLA and cytomegalovirus mismatch on lung transplantation survival and development of bronchiolitis obliterans syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900360-6

7 January 2021

Development of ELISA-detected anti-HLA antibodies precedes the development of bronchiolitis obliterans syndrome and correlates with progressive decline in pulmonary function after lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900360-6

7 January 2021

Sequelae of cytomegalovirus pulmonary infections in lung allograft recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900360-6

7 January 2021

Cytomegalovirus infection and pneumonitis. Impact after isolated lung transplantation. Washington University Lung Transplant Group

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900360-6

7 January 2021

Cytomegalovirus serologic status and postoperative infection correlated with risk of developing chronic rejection after pulmonary transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900360-6

7 January 2021

The impact of ganciclovir-resistant cytomegalovirus infection after lung transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900360-6

7 January 2021

Efficacy and cost effectiveness of oral ganciclovir in the prevention of cytomegalovirus disease after lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900360-6

7 January 2021

Impact of graft ischemic time on outcomes after bilateral sequential single-lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900360-6

7 January 2021

The Registry of the International Society for Heart and Lung Transplantation: seventeenth official report-2000

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900360-6

7 January 2021

Sequential measurement of peripheral blood allogeneic microchimerism levels and association with pulmonary function

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2801%2900360-6

7 January 2021

10.1016/S1053-2498(01)00360-6

Identifiers

DOI

1 reference

2 August 2017

1 reference